Investitionen im Ausland: Bayer will über 2 Milliarden Dollar in US-Werk investieren
Bayer plant eine neue Produktionsstätte in Ohio und investiert dafür 2,2 Milliarden Dollar. Was der Konzern sich von dem Standort verspricht.
New Albany, Ohio - The pharmaceutical and agricultural chemicals company Bayer plans to invest over $2.2 billion (€1.95 billion) in the United States to establish a new production facility. As a result, around 600 skilled jobs are expected to be created in New Albany, Ohio, according to the company's announcement. The site will integrate the production of pharmaceutical active ingredients and finished medications.
"For Bayer, the United States has long been an important production location and a significant center for innovation," stated Bayer CEO Bill Anderson. "At the new site, we will combine production expertise and skilled personnel to provide innovative and high-quality medications to patients in the United States and worldwide." Over the past five years, Bayer has invested more than $7 billion in pharmaceutical research and development and production in the United States.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
